Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components (Details) - Schedule of Accrued Liabilities

v3.23.2
Balance Sheet Components (Details) - Schedule of Accrued Liabilities - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Schedule of Accrued Liabilities [Abstract]    
Accrued labor costs $ 839 $ 1,487
Accrued drug development costs 609 228
Other 241 522
Total $ 1,689 $ 2,237